Long-segment SFA stenting - The dark sides: In-stent restenosis, clinical deterioration, and stent fractures

被引:216
作者
Schlager, O [1 ]
Dick, P [1 ]
Sabeti, S [1 ]
Amighi, J [1 ]
Mlekusch, W [1 ]
Minar, E [1 ]
Schillinger, M [1 ]
机构
[1] Univ Vienna, Vienna Gen Hosp, Div Angiol, Dept Internal Med 2, A-1090 Vienna, Austria
关键词
peripheral artery disease; superficial femoral artery; stents; nitinol stent; restenosis; stent fracture;
D O I
10.1583/05-1672.1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: To determine and compare the rates of in-stent restenosis, late clinical deterioration, and stent fractures in nitinol stents versus Wallstents implanted for suboptimal angioplasty in the superficial femoral artery (SFA). Methods: Interrogation of an angioplasty database identified 286 consecutive patients (178 men; mean age 67 10 years, range 44-87) with severe claudication (n=254) or critical limb ischemia (n=32) who had stents implanted after suboptimal angioplasty over a 5-year period. Wallstents with a mean stented lesion length of 107 +/- 71 mm were implanted in 116 patients, while nitinol stents were used in 170 patients: 45 SMART stents (mean stented lesion length 139 +/- 88 mm) and 125 Dynalink/Absolute stents (mean stented lesion length 125 +/- 84 mm). Patients were followed for in-stent restenosis (> 50%) by duplex ultrasound, clinical deterioration by at least 1 Fontaine stage compared to baseline, and stent fractures by biplanar radiography. Results: In-stent restenosis rates at 1, 2, and 3 years were 46%, 66%, and 72% for Wallstents compared to 20%, 36%, and 53% for nitinol stents (p < 0.001), respectively, without significant difference between the 2 nitinol stent groups (p=0.59). Clinical deterioration at 1, 2, and 3 years was found in 10%, 15%, and 18% with Wallstents versus 4%, 5%, and 5% with nitinol stents (p=0.014), respectively, without difference between the 2 nitinol stent groups (p=0.47). Fracture rates were 19% for Wallstents after a mean 43 +/- 24 months, 28% for SMART stents after mean 32 +/- 16 months, and 2% for Dynalink/Absolute stents after a mean 15 9 months. Conclusions: Intermediate-term in-stent restenosis remains a major problem even with current nitinol stent technology; however, clinical deterioration seems no matter of serious concern with SMART and Dynalink/Absolute stents. Stent fractures may be lower with Dynalink/Absolute stents, but randomized head-to-head comparisons are needed to validate these data.
引用
收藏
页码:676 / 684
页数:9
相关论文
共 16 条
[1]   Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study [J].
Becquemin, JP ;
Favre, JP ;
Marzelle, J ;
Nemoz, C ;
Corsin, C ;
Leizorovicz, A .
JOURNAL OF VASCULAR SURGERY, 2003, 37 (03) :487-494
[2]  
CAPEK P, 1991, CIRCULATION, V83, P70
[3]   PTA versus Palmaz stent placement in femoropopliteal artery obstructions: A multicenter prospective randomized study [J].
Cejna, M ;
Thurnher, S ;
Illiasch, H ;
Horvath, W ;
Waldenberger, P ;
Hornik, K ;
Lammer, J .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (01) :23-31
[4]   Sirolimus-eluting versus bare nitinol Stent for obstructive superficial femoral artery disease:: The SIROCCO II trial [J].
Duda, SH ;
Bosiers, M ;
Lammer, J ;
Scheinert, D ;
Zeller, T ;
Tielbeek, A ;
Anderson, J ;
Wiesinger, B ;
Tepe, G ;
Lansky, A ;
Mudde, C ;
Tielemans, H ;
Bérégi, JP .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (03) :331-338
[5]   Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease [J].
Duda, SH ;
Pusich, B ;
Richter, G ;
Landwehr, P ;
Oliva, VL ;
Tielbeek, A ;
Wiesinger, B ;
Hak, JB ;
Tielemans, H ;
Ziemer, G ;
Cristea, E ;
Lansky, A ;
Bérégi, JP .
CIRCULATION, 2002, 106 (12) :1505-1509
[6]   Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions [J].
Grimm, J ;
Müller-Hülsbeck, S ;
Jahnke, T ;
Hilbert, C ;
Brossmann, J ;
Heller, M .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (08) :935-941
[7]   FEMORAL AND POPLITEAL ARTERIES - REANALYSIS OF RESULTS OF BALLOON ANGIOPLASTY [J].
JOHNSTON, KW .
RADIOLOGY, 1992, 183 (03) :767-771
[8]   Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: A midterm follow-up [J].
Lugmayr, HF ;
Holzer, H ;
Kastner, M ;
Riedelsberger, H ;
Auterith, A .
RADIOLOGY, 2002, 222 (01) :37-43
[9]   Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty -: Results of a prospective randomized study [J].
Minar, E ;
Pokrajac, B ;
Maca, T ;
Ahmadi, R ;
Fellner, C ;
Mittlböck, M ;
Seitz, W ;
Wolfram, R ;
Pötter, R .
CIRCULATION, 2000, 102 (22) :2694-2699
[10]   DUPLEX SCANNING OF THE PERIPHERAL ARTERIES - CORRELATION OF THE PEAK VELOCITY RATIO WITH ANGIOGRAPHIC DIAMETER REDUCTION [J].
RANKE, C ;
CREUTZIG, A ;
ALEXANDER, K .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1992, 18 (05) :433-440